Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03012282 · ClinicalTrials.gov registry record · NA
CT Perfusion Images in Assessing Treatment Response in Patients With Pancreatic Cancer
A NA study, sponsored by University of Washington.
- Terminated
- Registry status
- NA
- Development phase
- 70
- Enrollment target
NCT03012282 is a NA study that was terminated before completion, run by University of Washington. The registered enrollment target is 70 participants.
The verdict
NCT03012282, a NA study, was terminated before completion, sponsored by University of Washington.
- TERMINATED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
Study Summary
This pilot clinical trial studies how well computed tomography (CT) perfusion images work in assessing treatment response in patients with pancreatic cancer. Analyzing specific measurements on the CT perfusion images may help doctors better determine how a tumor responds to chemotherapy and/or radiation therapy and may help guide treatment for patients with pancreatic cancer.
Interventions
- DIAGNOSTIC_TEST Computed Tomography Perfusion Imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2017-06-22 |
| Est. Completion | 2022-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03012282
The ClinicalTrials.gov registry entry for NCT03012282 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Computed Tomography Perfusion Imaging is the first listed.
NCT03012282 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03012282 about?
NCT03012282 is a clinical study titled "CT Perfusion Images in Assessing Treatment Response in Patients With Pancreatic Cancer". This pilot clinical trial studies how well computed tomography (CT) perfusion images work in assessing treatment response in patients with pancreatic cancer. Analyzing specific measurements on the CT perfusion images may help doctors better determine how a tumor responds to chemotherapy and/or radia...
What is the current status of trial NCT03012282?
This trial is currently terminated. It is a NA study. The enrollment target is 70 participants. The study started on 2017-06-22. Estimated completion is 2022-06-01.
What interventions are being tested in trial NCT03012282?
The interventions under investigation include: Computed Tomography Perfusion Imaging (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03012282?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.